Gregucci, Fabiana;
Spada, Sheila;
Barcellos-Hoff, Mary Helen;
Bhardwaj, Nina;
Hak, Charleen Chan Wah;
Fiorentino, Alba;
Guha, Chandan;
... Formenti, Silvia C; + view all
(2023)
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6(th) annual ImmunoRad conference.
OncoImmunology
, 12
(1)
, Article 2222560. 10.1080/2162402X.2023.2222560.
Preview |
Text
Updates on radiotherapy immunotherapy combinations Proceedings of 6th annual ImmunoRad conference.pdf - Published Version Download (1MB) | Preview |
Abstract
Focal radiation therapy (RT) has attracted considerable attention as a combinatorial partner for immunotherapy (IT), largely reflecting a well-defined, predictable safety profile and at least some potential for immunostimulation. However, only a few RT-IT combinations have been tested successfully in patients with cancer, highlighting the urgent need for an improved understanding of the interaction between RT and IT in both preclinical and clinical scenarios. Every year since 2016, ImmunoRad gathers experts working at the interface between RT and IT to provide a forum for education and discussion, with the ultimate goal of fostering progress in the field at both preclinical and clinical levels. Here, we summarize the key concepts and findings presented at the Sixth Annual ImmunoRad conference.
| Type: | Article |
|---|---|
| Title: | Updates on radiotherapy-immunotherapy combinations: Proceedings of 6(th) annual ImmunoRad conference |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1080/2162402X.2023.2222560 |
| Publisher version: | https://doi.org/10.1080/2162402X.2023.2222560 |
| Language: | English |
| Additional information: | © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
| Keywords: | dose and fractionation; FLASH radiotherapy; immune checkpoint inhibitors; immunomodulators; lymph node sparing; tumor-associated macrophages |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10172964 |
Archive Staff Only
 |
View Item |
